Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries

SUMMARY The epidemiology of seasonal influenza is influenced by age. During the influenza season, the European Influenza Surveillance Network (EISN) reports weekly virological and syndromic surveillance data [mostly influenza-like illness (ILI)] based on national networks of sentinel primary-care providers. Aggregated numbers by age group are available for ILI, but not linked to the virological data. At the end of the influenza season 2012/2013, all EISN laboratories were invited to submit a subset of their virological data for this season, including information on age. The analysis by age group suggests that the overall distribution of circulating (sub)types may mask substantial differences between age groups. Thus, in cases aged 5–14 years, 75% tested positive for influenza B virus whereas all other age groups had an even distribution of influenza A and B viruses. This means that the intepretation of syndromic surveillance data without age group-specific virological data may be misleading. Surveillance at the European level would benefit from the reporting of age-specific influenza data.

[1]  Young Keun Kim,et al.  A Comparison of the Clinical and Epidemiological Characteristics of Adult Patients with Laboratory-Confirmed Influenza A or B during the 2011–2012 Influenza Season in Korea: A Multi-Center Study , 2013, PloS one.

[2]  N. Cox,et al.  Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.

[3]  M. Connock,et al.  Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. , 2006, Vaccine.

[4]  M. Valenciano,et al.  Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  Mark Loeb,et al.  Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis , 2013, BMJ.

[6]  C. Bridges,et al.  The underrecognized burden of influenza in young children. , 2006, The New England journal of medicine.

[7]  N. Hens,et al.  Contribution of respiratory pathogens to influenza-like illness consultations , 2012, Epidemiology and Infection.

[8]  R. Pebody,et al.  A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period , 2012 .

[9]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[10]  Louise Pelletier,et al.  Age-specific Differences in Influenza A Epidemic Curves: Do Children Drive the Spread of Influenza Epidemics? , 2011, American journal of epidemiology.

[11]  Cécile Viboud,et al.  Risk factors of influenza transmission in households. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.

[12]  Anne M Johnson,et al.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study , 2014, The Lancet Respiratory Medicine.

[13]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[14]  P. Zucs,et al.  Influenza season 2012–2013 in Europe: moderate intensity, mixed (sub)types , 2014, Epidemiology and Infection.

[15]  L. Grohskopf,et al.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[16]  D M Fleming,et al.  The evolution of influenza surveillance in Europe and prospects for the next 10 years. , 2003, Vaccine.

[17]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[18]  Matthew E. Falagas,et al.  Age Distribution of Cases of 2009 (H1N1) Pandemic Influenza in Comparison with Seasonal Influenza , 2011, PloS one.

[19]  I. Bonmarin,et al.  Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  U. Buchholz,et al.  Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007–2011 , 2012, PloS one.

[21]  H. Aizawa,et al.  Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients , 2003, Respirology.

[22]  T. Heikkinen,et al.  Burden of paediatric influenza in Western Europe: a systematic review , 2012, BMC Public Health.

[23]  R. Schmidt-Ott,et al.  Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[24]  S. Mukhi,et al.  Association between Patient Age and Influenza A Subtype during Influenza Outbreaks , 2010, Infection Control & Hospital Epidemiology.

[25]  M Elizabeth Halloran,et al.  Population-wide benefits of routine vaccination of children against influenza. , 2005, Vaccine.

[26]  Lauren A. Wu,et al.  Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. , 2012, Vaccine.